000 | 01702 a2200517 4500 | ||
---|---|---|---|
005 | 20250516134748.0 | ||
264 | 0 | _c20131021 | |
008 | 201310s 0 0 eng d | ||
022 | _a1476-5551 | ||
024 | 7 |
_a10.1038/leu.2013.52 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLogan, A C | |
245 | 0 | 0 |
_aMinimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. _h[electronic resource] |
260 |
_bLeukemia _cAug 2013 |
||
300 |
_a1659-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
650 | 0 | 4 | _aHigh-Throughput Nucleotide Sequencing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin Heavy Chains _xgenetics |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm, Residual _xdiagnosis |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aZhang, B | |
700 | 1 | _aNarasimhan, B | |
700 | 1 | _aCarlton, V | |
700 | 1 | _aZheng, J | |
700 | 1 | _aMoorhead, M | |
700 | 1 | _aKrampf, M R | |
700 | 1 | _aJones, C D | |
700 | 1 | _aWaqar, A N | |
700 | 1 | _aFaham, M | |
700 | 1 | _aZehnder, J L | |
700 | 1 | _aMiklos, D B | |
773 | 0 |
_tLeukemia _gvol. 27 _gno. 8 _gp. 1659-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2013.52 _zAvailable from publisher's website |
999 |
_c22514298 _d22514298 |